Contents

Current Cancer Therapy Reviews, Volume 2 - Number 4

Familial Central Nervous System Tumor Syndromes

, 2(4): 281 - 291

Andreas F. Hottinger, Yasmin Khakoo and Lauren E. Abrey


DOI: 10.2174/157339406778699222




Penetration of Tumor Therapy Interesting Substances in Non-Vascularized Metastases: Review of Studies in Multicellular Spheroids

, 2(4): 293 - 304

Jorgen Carlsson and Lars Gedda


DOI: 10.2174/157339406778699213




The ABCs of Targeting Raf: Novel Approaches to Cancer Therapy

, 2(4): 305 - 314

Rebecca Kinkade, Piyali Dasgupta and Srikumar Chellappan


DOI: 10.2174/157339406778699204




Adjuvant Therapy in Elderly Patients with Early Breast Cancer

, 2(4): 315 - 325

Silvia Dellapasqua, Alessandra Balduzzi, Aron Goldhirsch and Marco Colleoni


DOI: 10.2174/157339406778699169




The Role of FDA in the Regulation of Anti-Cancer Drugs

, 2(4): 327 - 329

Ramzi N. Dagher and Richard Pazdur


DOI: 10.2174/157339406778699196




Transcriptional Regulation of Survivin: New Target for Cancer Treatment

, 2(4): 331 - 339

Muxiang Zhou


DOI: 10.2174/157339406778699178




Estrogen in Prostate Cancer - Friend or Foe?

, 2(4): 341 - 349

Eva Corey


DOI: 10.2174/157339406778699231




Cancer Rehabilitation: Recommendations for Integrating Exercise Programming in the Clinical Practice Setting

, 2(4): 351 - 360

Margaret L. McNeely, Carolyn J. Peddle, Matthew Parliament and Kerry S. Courneya


DOI: 10.2174/157339406778699187




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science